Initiatives, Collaborations, and Label Updates Introduced in the Q1 2026 CAR-T Therapies Market

Bristol Myers Squibb, the maker of Abecma and Breyanzi, informed readers that the Standing in the Gaap program was launching a survey and promoted a new collaboration.

Gilead stated that it was acquiring Arcellx, which touted anito-cel data presentations it was making at a conference.

Legend Biotech announced the presentation of Carvykti data and business updates at conferences. Johnson and Johnson also discussed a manufacturing investment, the brand’s availability, and a price update.

A press release from Kite Pharma advised readers about a label update to Yescarta’s prescribing information.